198 related articles for article (PubMed ID: 8605571)
21. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
Hanahan D
Nature; 1985 May 9-15; 315(6015):115-22. PubMed ID: 2986015
[TBL] [Abstract][Full Text] [Related]
22. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
23. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
24. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
25. Peptide YY expression is an early event in colonic endocrine cell differentiation: evidence from normal and transgenic mice.
Upchurch BH; Fung BP; Rindi G; Ronco A; Leiter AB
Development; 1996 Apr; 122(4):1157-63. PubMed ID: 8620842
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
27. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
Bani D; Bani Sacchi T; Biliotti G
Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
[TBL] [Abstract][Full Text] [Related]
28. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse.
Hamaguchi K; Gaskins HR; Leiter EH
Diabetes; 1991 Jul; 40(7):842-9. PubMed ID: 1647994
[TBL] [Abstract][Full Text] [Related]
29. Generation and characterization of a transgenic mouse model for pancreatic cancer.
Sun Q; Feng J; Wei XL; Zhang R; Dong SZ; Shen Q; Dong J; Li HD; Hu YH
World J Gastroenterol; 2006 May; 12(17):2785-8. PubMed ID: 16718771
[TBL] [Abstract][Full Text] [Related]
30. Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones.
Myrsén-Axcrona U; Ekblad E; Sundler F
Regul Pept; 1997 Feb; 68(3):165-75. PubMed ID: 9100283
[TBL] [Abstract][Full Text] [Related]
31. The endocrine cells of the pancreas and related tumours. Ultrastructural study and classification.
Capella C; Solcia E; Frigerio B; Buffa R; Usellini L; Fontana P
Virchows Arch A Pathol Anat Histol; 1977 Apr; 373(4):327-52. PubMed ID: 193245
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth.
Power RF; Holm R; Bishop AE; Varndell IM; Alpert S; Hanahan D; Polak JM
Gut; 1987; 28 Suppl(Suppl):121-9. PubMed ID: 2826309
[TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
[TBL] [Abstract][Full Text] [Related]
34. MEN I pancreas: a histological and immunohistochemical study.
Thompson NW; Lloyd RV; Nishiyama RH; Vinik AI; Strodel WE; Allo MD; Eckhauser FE; Talpos G; Mervak T
World J Surg; 1984 Aug; 8(4):561-74. PubMed ID: 6207668
[No Abstract] [Full Text] [Related]
35. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
[TBL] [Abstract][Full Text] [Related]
36. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
[TBL] [Abstract][Full Text] [Related]
37. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor.
Upchurch BH; Aponte GW; Leiter AB
Development; 1994 Feb; 120(2):245-52. PubMed ID: 8149907
[TBL] [Abstract][Full Text] [Related]
38. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
39. Secretory granules in benign and malignant glucagonomas of the pancreas.
Nakanishi I; Katsuda S; Kajikawa K; Yonemura Y; Konishi K; Miwa K
Acta Pathol Jpn; 1984 Jan; 34(1):95-102. PubMed ID: 6328864
[TBL] [Abstract][Full Text] [Related]
40. Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types.
Lopez MJ; Upchurch BH; Rindi G; Leiter AB
J Biol Chem; 1995 Jan; 270(2):885-91. PubMed ID: 7822327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
